Allan Reine
Overview
Allan Reine received $2M in total compensation, including $416K in salary, at Foghorn Therapeutics in 2021. Allan Reine also received an average of $1M at Pieris Pharmaceuticals between 2017 and 2018.
Source: SEC filings on April 29, 2022, June 18, 2019, and June 14, 2018.
Related executives
We found 12 more executives who work or worked at Foghorn Therapeutics and Pieris Pharmaceuticals.
Adrian Gottschalk
Foghorn Therapeutics
Chief Executive Officer
Alfonso Quintás-Cardama
Foghorn Therapeutics
Chief Medical Officer
Stephen Yoder
Pieris Pharmaceuticals
Chief Executive Officer
Steven Bellon
Foghorn Therapeutics
Chief Scientific Officer
Thomas Bures
Pieris Pharmaceuticals
Chief Financial Officer
Shane Olwill
Pieris Pharmaceuticals
Former Senior Vice President and Chief Development Officer
Carl Decicco
Foghorn Therapeutics
Chief Scientific Officer
Samuel Agresta
Foghorn Therapeutics